Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse

Brain Research Bulletin

Volumn 109, Issue , 2014, Pages 88-98

  Wu, Li ^a   Jiang, Yongjun ^a   Zhu, Juehua ^a   Wen, Zhuoyu ^a   Xu, Xiaohui ^a   Xu, Xiaomeng ^a   Xie, Yi ^a   Yang, Lian ^a   Xu, Lili ^a   Lan, Wenya ^a   Xu, Gelin ^a   Liu, Xinfeng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Blood brain barrier; Microarray analysis; Nf b; Orosomucoid; Stroke; Vascular endothelial growth factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OROSOMUCOID; OROSOMUCOID 1; RECOMBINANT VASCULOTROPIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; NERVE PROTEIN; PROTEIN BINDING; VASCULOTROPIN A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOINFORMATICS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; MALE; MICROARRAY ANALYSIS; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REPERFUSION; ANIMAL; BRAIN EDEMA; BRAIN INFARCTION; C57BL MOUSE; CELL COUNT; CEREBRAL ARTERY DISEASE; COMPLICATION; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; CELL COUNT; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROSOMUCOID; PROTEIN BINDING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908391005     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.09.007     Document Type: Article

References (36)

1. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
2. Chi O.Z., Hunter C., Liu X., Weiss H.R. Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp. Neurol. 2007, 204:283-287.
3. Dikov M.M., Oyama T., Cheng P., Takahashi T., Takahashi K., Sepetavec T., et al. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Cancer Res. 2001, 61:2015-2021.
4. Dragoni S., Laforenza U., Bonetti E., Lodola F., Bottino C., Berra-Romani R., et al. Vascular endothelial growth factor stimulates endothelial colony forming cells proliferation and tubulogenesis by inducing oscillations in intracellular Ca2+ concentration. Stem Cells 2011, 29:1898-1907.
5. Fournier T., Medjoubi N.N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482:157-171.
6. Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998, 92:4150-4166.
7. Giacca M., Zacchigna S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 2012, 19:622-629.
8. Greenberg D.A., Jin K. Vascular endothelial growth factors (VEGFs) and stroke. Cell. Mol. Life Sci. 2013, 70:1753-1761.
9. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
10. Herz J., Reitmeir R., Hagen S.I., Reinboth B.S., Guo Z., Zechariah A., et al. Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol. Dis. 2012, 45:1077-1085.
11. Huang Z., Ung T. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Curr. Drug Metab. 2013, 14:226-238.
12. Kanazawa M., Igarashi H., Kawamura K., Takahashi T., Kakita A., Takahashi H., et al. Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. J. Cereb. Blood Flow Metab. 2011, 31:1461-1474.
13. Keith J.C., Albert L.M., Leathurby Y., Follettie M., Wang L., Borges-Marcucci L., et al. The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis. Arthritis Res. Ther. 2005, 7:R427-R438.
14. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 2001, 276:7614-7620.
15. Kim J.H., Lee Y.W., Park K.A., Lee W.T., Lee J.E. Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30:943-949.
16. Kimura R., Nakase H., Tamaki R., Sakaki T. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke 2005, 36:1259-1263.
17. Koyama J., Miyake S., Sasayama T., Chiba Y., Kondoh T., Kohmura E. The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats. Kobe J. Med. Sci. 2010, 56:E1-E11.
18. Kupatt C., Hinkel R., Vachenauer R., Horstkotte J., Raake P., Sandner T., et al. VEGF165 transfection decreases postischemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation. FASEB J. 2003, 17:705-707.
19. Lee Y.M., Miau L.H., Chang C.J., Lee S.C. Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140. Mol. Cell. Biol. 1996, 16:4257-4263.
20. Li Z., Wang R., Li S., Wei J., Zhang Z., Li G., et al. Intraventricular pre-treatment with rAAV-VEGF induces intracranial hypertension and aggravates ischemic injury at the early stage of transient focal cerebral ischemia in rats. Neurol. Res. 2008, 30:868-875.
21. Manoonkitiwongsa P.S. Critical questions for preclinical trials on safety and efficacy of vascular endothelial growth factor-based therapeutic angiogenesis for ischemic stroke. CNS Neurol. Disord. Drug Targets 2011, 10:215-234.
22. Marumo T., Schini-Kerth V.B., Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999, 48:1131-1137.
23. Muchitsch E.M., Schwarz H.P. Beneficial effect of albumin therapy attributable to alpha1-acid glycoprotein?. Stroke 2003, 34:4-5. author reply 4-5.
24. Ohm J.E., Shurin M.R., Esche C., Lotze M.T., Carbone D.P., Gabrilovich D.I. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. J. Immunol. 1999, 163:3260-3268.
25. Orlandi A., Ferlosio A., Arcuri G., Scioli M.G., De Falco S., Spagnoli L.G. Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-kappaB/IAP-1 pathway. Cardiovasc. Res. 2010, 85:214-223.
26. Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D.P., et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 1998, 160:1224-1232.
27. Reitmeir R., Kilic E., Reinboth B.S., Guo Z., ElAli A., Zechariah A., et al. Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain. Acta Neuropathol. 2012, 123:273-284.
28. Schnitzer J.E., Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability. Am. J. Physiol. 1992, 263:H48-H55.
29. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
30. Shen B.J., Chang C.J., Lee H.S., Tsai W.H., Miau L.H., Lee S.C. Transcriptional induction of the agp/ebp (c/ebp beta) gene by hepatocyte growth factor. DNA Cell Biol. 1997, 16:703-711.
31. Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 2000, 12:4243-4254.
32. Valable S., Montaner J., Bellail A., Berezowski V., Brillault J., Cecchelli R., et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J. Cereb. Blood Flow Metab. 2005, 25:1491-1504.
33. Wu L., Xu L., Xu X., Fan X., Xie Y., Yang L., et al. Keep warm and get success: the role of postischemic temperature in the mouse middle cerebral artery occlusion model. Brain Res. Bull. 2014, 101:12-17.
34. Yuan W., Li G., Zeng M., Fu B.M. Modulation of the blood-brain barrier permeability by plasma glycoprotein orosomucoid. Microvasc. Res. 2010, 80:148-157.
35. Zhang S., Mark K.S. alpha1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells. Microvasc. Res. 2012, 84:161-168.
36. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000, 106:829-838.